Aminex Therapeutics, Inc.
Biotechnology company · Kenmore, Washington, United States
Aminex Therapeutics, Inc. is a biotechnology company headquartered in Kenmore, Washington, United States. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2025.
Profile compiled from public records. Is this your company? Request a correction or update
Aminex Therapeutics at a glance
Typebiotechnology company
HeadquartersKenmore, Washington, United States
SEC CIK1613386
What does Aminex Therapeutics do?
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $15.1 million sold (2025).
Frequently asked questions about Aminex Therapeutics
Where is Aminex Therapeutics headquartered?
Aminex Therapeutics, Inc. is headquartered in Kenmore, Washington, United States.
What does Aminex Therapeutics do?
Aminex Therapeutics, Inc. is a biotechnology company.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences